Page last updated: 2024-12-11

8-hydroxyadenine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

8-hydroxyadenine: xanthine oxidase reacted adenine metabolite in epidermis of hairless mice; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

8-oxoadenine : An oxopurine that is adenine bearing a single oxo substituent at position 8. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

8-hydroxyadenine : A nucleobase analogue that is adenine bearing a single hydroxy substituent at position 8. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5355054
CHEMBL ID150192
CHEBI ID134105
CHEBI ID134104
SCHEMBL ID42335
MeSH IDM0043887

Synonyms (44)

Synonym
8-hydroxyadenine
purin-8(9h)-one, 6-amino-
oxyadenine
1h-purin-6-amine, 8-hydroxy-
8-oxoadenine
6-amino-8-purinol
nsc24123
21149-26-8
6-amino-8-hydroxypurine
oksaden
nsc-24123
oxaden
OPREA1_197965
OPREA1_428248
NCGC00096115-01
7,8-dihydro-8-oxoadenine
8-oxoa
8-oxo-7,8-dihydroadenine
6-amino-purin-8-ol
CHEBI:134105
8-hydroxy-1h-purin-6-amine
6-amino-1,7-dihydro-8h-purin-8-one
CHEBI:134104
CHEMBL150192
6-amino-7,9-dihydropurin-8-one
8-hydroxy adenine
6-amino-7,9-dihydro-8h-purin-8-one
FT-0669297
AKOS000662851
6-amino-7h-purin-8-ol
nsc 24123
8h-purin-8-one, 6-amino-1,7-dihydro-
7,8-dhoa
ai3-50267
SCHEMBL42335
W-201866
DTXSID70175390
8-hydroxyadenin
6-amino-purin-8(9h)-one
6-amino-9h-purin-8-ol
STL510787
E78317
A912168
BS-48723

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"1 mg/kg, which was 30-fold potent than that of Imiquimod, and showed a good oral bioavailability (F=81%)."( Synthesis and structure-activity relationships of 2-amino-8-hydroxyadenines as orally active interferon inducing agents.
Hirota, K; Ichii, S; Isobe, Y; Kawakami, H; Kurimoto, A; Ogino, T; Ogita, H; Sajiki, H; Takaku, H; Tobe, M, 2003
)
0.56
"03 mg/kg, which was approximately 100-fold more potent than that of Imiquimod, and showed an excellent oral bioavailability (F=40%) which was 10-fold improved over 5, a lead compound (F=4%)."( Synthesis and evaluation of 2-substituted 8-hydroxyadenines as potent interferon inducers with improved oral bioavailabilities.
Hirota, K; Ichii, S; Isobe, Y; Kawakami, H; Kurimoto, A; Ogino, T; Ogita, H; Sajiki, H; Takaku, H; Tobe, M, 2004
)
0.59

Dosage Studied

ExcerptRelevanceReference
" Data from correlation analysis of the log ratios for normal tissues from cancer were consistent with an age-dependent, dose-response relationship."( Age-related radical-induced DNA damage is linked to prostate cancer.
Barker, EA; Johnson, PM; Malins, DC; Polissar, NL; Vinson, MA; Wheeler, TM, 2001
)
0.31
" When dosed into the lung the compounds were rapidly metabolized and short-term exposure of the 'antedrug' was sufficient to activate the IFN pathway."( Biological characterization of a novel class of toll-like receptor 7 agonists designed to have reduced systemic activity.
Aoki, M; Benjamin, AD; Biffen, M; Doyle, I; Edwards, S; Eiho, K; Fraser, NJ; Hawkins, SL; Holness, E; Leishman, AJ; Matsui, H; McInally, T; Murray, CM; Satterthwaite, G; Takaku, H; Tomizawa, H; Wada, H, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
bacterial metaboliteAny prokaryotic metabolite produced during a metabolic reaction in bacteria.
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
6-aminopurinesAny compound having 6-aminopurine (adenine) as part of its structure.
oxopurine
nucleobase analogueA molecule that can substitute for a normal nucleobase in nucleic acids.
6-aminopurinesAny compound having 6-aminopurine (adenine) as part of its structure.
nucleobase analogueA molecule that can substitute for a normal nucleobase in nucleic acids.
heteroaryl hydroxy compoundAny organic aromatic compound having one or more hydroxy groups attached to a heteroarene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID445473Selectivity ratio of Ki for adenine 1 receptor in HEK293 cells to Ki for adenine 1 receptor in rat brain cortical membrane2009Journal of medicinal chemistry, Oct-08, Volume: 52, Issue:19
Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family.
AID445471Displacement of [3H]adenine from adenine 1 receptor in HEK293 cells by liquid scintillation counting2009Journal of medicinal chemistry, Oct-08, Volume: 52, Issue:19
Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family.
AID445467Displacement of [3H]adenine from adenine 1 receptor in rat brain cortical membrane by liquid scintillation counting2009Journal of medicinal chemistry, Oct-08, Volume: 52, Issue:19
Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family.
AID132946Minimum effective concentration required for more than 1 IU/mL induction of IFN using mice spleen cells2002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
Discovery of 8-hydroxyadenines as a novel type of interferon inducer.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (79)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (6.33)18.7374
1990's24 (30.38)18.2507
2000's31 (39.24)29.6817
2010's15 (18.99)24.3611
2020's4 (5.06)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.62 (24.57)
Research Supply Index4.43 (2.92)
Research Growth Index5.05 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (2.47%)5.53%
Reviews4 (4.94%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other75 (92.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]